Arax Advisory Partners’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
Arax Advisory Partners's MRNA Position: Q2 2026 in Review
Arax Advisory Partners opened a new position in Moderna (MRNA) in Q2 2026: 11,012 shares worth $771K. The stake represents 0.01% of the portfolio and ranks #1356 among its holdings. This is a return to the name: Arax Advisory Partners previously reported a position in MRNA as recently as Q4 2025.
Arax Advisory Partners first reported a position in MRNA in Q2 2021 and has held it in 9 quarters since. 780 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.
- Arax Advisory Partners held 11,012 shares of Moderna worth $771K as of Q2 2026.
- Moderna was a new Arax Advisory Partners position in Q2 2026.
- Moderna made up 0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #1356 holding.
- Arax Advisory Partners first reported a position in Moderna in Q2 2021 and has held it in 9 quarters since.
- 780 funds tracked by Wall St. Rank held Moderna as of Q2 2026.
Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.